Aspen Aerogels, Inc. (NYSE:ASPN) Receives Average Rating of "Buy" from Analysts

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) has earned an average rating of "Buy" from the ten brokerages that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $19.11.

A number of analysts recently weighed in on the stock. B. Riley decreased their price target on shares of Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating for the company in a research report on Wednesday, February 19th. StockNews.com upgraded shares of Aspen Aerogels to a "sell" rating in a report on Wednesday, February 19th. Craig Hallum cut their price objective on shares of Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating on the stock in a report on Friday, February 14th. Seaport Res Ptn lowered shares of Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 12th. Finally, Roth Mkm cut their price objective on shares of Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a report on Friday, February 14th.

Institutional Investors Weigh In On Aspen Aerogels

A number of institutional investors have recently modified their holdings of ASPN. Sandia Investment Management LP acquired a new stake in shares of Aspen Aerogels in the 4th quarter valued at about $89,000. AlphaQuest LLC raised its stake in shares of Aspen Aerogels by 54.0% in the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company's stock valued at $135,000 after purchasing an additional 3,998 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new stake in shares of Aspen Aerogels in the 4th quarter valued at about $164,000. Connors Investor Services Inc. acquired a new stake in shares of Aspen Aerogels in the 4th quarter valued at about $168,000. Finally, Journey Strategic Wealth LLC acquired a new stake in Aspen Aerogels during the fourth quarter worth about $178,000. Institutional investors and hedge funds own 97.64% of the company's stock.

Remove Ads

Aspen Aerogels Stock Up 6.6 %

Aspen Aerogels stock traded up $0.45 during trading on Tuesday, reaching $7.38. 1,179,527 shares of the company's stock were exchanged, compared to its average volume of 1,789,648. The company's 50-day moving average is $10.33 and its two-hundred day moving average is $16.31. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. Aspen Aerogels has a 52-week low of $6.70 and a 52-week high of $33.15. The firm has a market cap of $605.92 million, a price-to-earnings ratio of 46.15 and a beta of 2.28.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. On average, analysts predict that Aspen Aerogels will post 0.17 earnings per share for the current year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.